Distribution of score = 5 (indicating best recovery) for each item in the QoR-10 score* and anxiety from anesthesia scores_ Phase 1 (n=300) vs_ Phase 3 (n-300)
| Measure | Percentage of population with score = 5 (maximum score for each item) | Significance by chi-square | |
|---|---|---|---|
| Phase 1 | Phase 3 | ||
| Spoke easily | 99.0% | 99.7% | 0.512 |
| Did not experience depression | 99.0% | 99.7% | 0.570 |
| Communicated easily with surrounding people | 99.0% | 100% | 0.389 |
| Breathed easily | 98.0% | 99% | 0.221 |
| Reported no mental distress | 97.7% | 97.3% | 0.570 |
| Reported no nausea/vomiting | 96.3% | 97.3% | 0.731 |
| Reported no other complaints | 95.3% | 94% | 0.489 |
| Moved/walked easily | 93.3% | 97.3% | 0,146 |
| Reported no shivering | 92.7% | 97.7% | 0.023 |
| NRS score < 4** | 49.7% | 79% | 0.000 |
| QoR-10 score (median, IQR) | 49(49–50) | 50(49–50) | <0.001 |
| Anxiety from anesthesia | 5.92(3.55) | 5.78(3.14) | 0.617 |
| - Worry about anesthesia | 11% | 8.3% | 0.495 |
| - Thoughts about anesthesia | 9% | 7.7% | 0.494 |
| - Wanted to know more about anesthesia | 5% | 6.3% | 0.560 |
Patient and hospitalization characteristics, Phase 1 (n=300) vs_ Phase 3 (n-300)
| Variable | Summary Measure | Significance by chi-square | ||
|---|---|---|---|---|
| Phase 1 | Phase 3 | |||
| Age (median (IQR)) | 50 (36–65) | 53(36–66) | 0.734 | |
| Sex (n(%)) | Female | 121(40.3) | 101(33.7) | 0.091 |
| Male | 179(59.7) | 199(66.3) | ||
| ASA (n(%)) | 1 | 146(48.7) | 117(39) | 0.053 |
| 2 | 136(45.3) | 168(56) | ||
| 3 | 18(6) | 15(5) | ||
| Anesthesia type (n (%)) | Balanced | 9 (3.0) | 17(5.7) | 0.275 |
| TIVA | 247 (82.3) | 241(80.3) | ||
| TIVA + block | 44 (14.7) | 42(14.0) | ||
| Preplanned hospitalization* (n (%)) | No | 201(67) | 226(75.3) | 0.024 |
| Yes | 99(33.0) | 74(24.7) | ||
| Surgery Type | Orthopedics | 75 (25.0) | 75 (25.0) | 1.000 |
| ENT | 65 (21.7) | 67(22.3) | 0.844 | |
| General surgery | 58 (19.3) | 66(22.0) | 0.465 | |
| Urology | 33 (11.0) | 57(19.0) | 0.06 | |
| Breast | 20 (6.7) | 2(0.7) | 0.000 | |
| Plastic | 12 (4.0) | 6(2.0) | 0.151 | |
| Vascular | 10 (3.3) | 10(3.3) | 1.000 | |
| Maxillo-facial | 9(3.0) | 9 (3.0) | 1.000 | |
| Eye | 8(2.7) | 6(2.0) | 0.569 | |
| Comorbidities | Hypertension | 116(38.7) | 73(24.3) | 0.777 |
| Diabetes mellitus | 76(25.3) | 13(11.0) | 0.117 | |
| Smoking | 46(15.3) | 28(9.3) | 0.058 | |
| Obesity | 43(14.3) | 41(13.7) | 0.261 | |
| Cardiac | 32(10.7) | 0(0.0) | 0.000 | |
| Asthma | 14(4.7) | 12(4.0) | 0.832 | |
| COPD | 11(3.7) | 6(2.0) | 0,433 | |
| Hypothyroidism | 9(3.0) | 0(0.0) | 0.003 | |
| Renal disease | 9(3.0) | 0(0.0) | 0.004 | |
| Chronic anxiety | 8(2.7) | 0(0.0) | 0.014 | |
| Anesthesia time (median, IQR) | 63(44–97) | 60(37–100) | 0.040 | |
| PACU time (median, IQR)** | 90(60–120) | 100(80–129) | 0.000 | |